Comparing the performance ofFAM19A4methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study)-Reference-Cited by-同舟云学术

Comparing the performance ofFAM19A4methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study)

Published:2015-09-14 Issue:4 Volume:138 Page:992-1002
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Luttmer Roosmarijn¹,De Strooper Lise M.A.¹,Berkhof Johannes²,Snijders Peter J.F.¹,Dijkstra Maaike G.³,Uijterwaal Margot H.⁴,Steenbergen Renske D.M.¹,van Kemenade Folkert J.⁵,Rozendaal Lawrence¹,Helmerhorst Theo J.M.⁶,Verheijen Rene H.M.⁷,Ter Harmsel W. Abraham⁸,Van Baal W. Marchien⁴,Graziosi Peppino G.C.M.⁹,Quint Wim G.V.¹⁰,Heideman Daniëlle A.M.¹,Meijer Chris J.L.M.¹

Affiliation:

1. Department of Pathology; VU University Medical Center, Amsterdam, The Netherlands

2. Department of Epidemiology and Biostatistics; VU University Medical Center; Amsterdam The Netherlands

3. Department of Obstetrics and Gynecology; VU University Medical Center; Amsterdam The Netherlands

4. Department of Obstetrics and Gynecology; Flevo Hospital; Almere The Netherlands

5. Department of Pathology; Erasmus Medical Center; Rotterdam The Netherlands

6. Department of Obstetrics and Gynecology; Erasmus MC University Medical Center; Rotterdam The Netherlands

7. Department of Obstetrics and Gynecology; University Medical Center Utrecht; Utrecht The Netherlands

8. Department of Gynecology; Roosevelt Clinic; Leiden The Netherlands

9. Department of Obstetrics and Gynecology; Sint Antonius Hospital; Nieuwegein The Netherlands

10. DDL Diagnostic Laboratory; Rijswijk The Netherlands

Funder

KWF Kankerbestrijding

European Research Council

Seventh Framework Programme

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions;Steenbergen;Nat Rev Cancer,2014

2. Human papillomavirus is a necessary cause of invasive cervical cancer world-wide;Walboomers;J Pathol,1999

3. Human papillomavirus and Papanicolaou tests to screen for cervical cancer;Naucler;N Engl J Med,2007

4. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials;Ronco;Lancet,2013

5. Primary human papillomavirus testing in organized cervical screening;Dillner;Curr Opin Obstet Gynecol,2013

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA methylation at individual CpG-sites of EPB41L3, HTERT and FAM19A4 are useful for detection of cervical high-grade squamous intraepithelial lesions (HSIL) or worse: Analysis of individual CpG-sites outperforms averaging;Tumour Virus Research;2024-12

2. A novel methylation-detection panel for HPV associated high-grade squamous intraepithelial lesion and cervical cancer screening;2024-08-09

3. The construction and preliminary validation of methylation haplotype load markers of multiple genes for cervical cancer screenings;2024-04-30

4. PAX1 and SOX1 Gene Methylation as a Detection and Triage Method for Cervical Intraepithelial Neoplasia Diagnosis;Acta Cytologica;2024

5. Comparing the Costs and Diagnostic Outcomes of Replacing Cytology with the QIAsure DNA Methylation Test as a Triage within HPV Primary Cervical Cancer Screening in The Netherlands;Diagnostics;2023-12-06